News & Events

Stay informed with the latest news, scientific advancements, company milestones, and industry insights as we continue to push the boundaries of research and innovation.

09.12.25 / CIMA Sciences + Rubio Metabolomics to Exhibit at the 2025 ADA 85th Scientific Sessions

The American Diabetes Association (ADA)’s 85th Scientific Sessions will be held in Chicago from June 20-23, 2025, bringing together leading experts to discuss the latest breakthroughs in diabetes research, prevention, and care. This year’s event will feature over 200 sessions, including cutting-edge clinical studies, symposia, and panel discussions, with a focus on topics like beta cell therapy, technology and innovation, and obesity management. Attendees can also participate in the Innovation Challenge, where startups pitch novel ideas to improve the lives of people with diabetes according to the American Diabetes Association. The conference will be available both in-person and on-demand. 

Event Details:
  • Date: June 20-23, 2025
  • Location: McCormick Place Convention Center – Chicago, Illinois
  • Booth #:

11.07.25 / CIMA Sciences to Exhibit and Sponsor at the The Liver Meeting 2025

The Liver Meeting 2025, organized by the American Association for the Study of Liver Diseases (AASLD), will be held in Washington, DC, from November 7-11. This premier event brings together clinicians, researchers, and associates from around the globe to discuss the latest advancements in liver disease research, treatment, and transplantation. Attendees can expect to participate in scientific sessions, workshops, and networking opportunities. The meeting will also feature an exhibit hall with over 150 exhibitors showcasing cutting-edge products and services.


Event Details:
  • Date: November 7-11, 2025
  • Location: Walter E. Washington Convention Center – Washington D.C.
  • Abstract Submitted


Advancing Non-Invasive Diagnostics.

info
Contact Us

300E Sonterra Blvd., Suite 1110
San Antonio, Texas 78258

check_circle
Order OWLiver® Test

OWLiver® is a non-invasive blood test to assess MASLD. It analyzes a panel of biomarkers through metabolomics methodology.